Results 11 to 20 of about 3,036,447 (259)

Extracellular vesicles in non-alcoholic and alcoholic fatty liver diseases

Liver Research, 2018
Fatty liver diseases, non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD) are the most common causes of chronic liver diseases around the world.
Akiko Eguchi, Ariel E. Feldstein
doaj   +2 more sources

High serum N-terminal propeptide of procollagen type III concentration is associated with liver diseases

Gastroenterology Review, 2017
Introduction : N-terminal propeptide of procollagen type III (PIIINP) is generated during the synthesis of type III collagen. PIIINP can be measured in the serum as an indicator of liver fibrosis and cirrhosis.
Monika Gudowska, Ewa Gruszewska, Anatol Panasiuk, Bogdan Cylwik, Magdalena Swiderska, Robert Flisiak, Maciej Szmitkowski, Lech Chrostek   +7 more
doaj   +2 more sources

Elevated endotoxin levels in non-alcoholic fatty liver disease [PDF]

, 2010
Background: Emerging data indicate that gut-derived endotoxin may contribute to low-grade systemic inflammation in insulin resistant states. This study aimed to examine the importance of serum endotoxin and inflammatory markers in non-alcoholic fatty ...
Ashour, E., Steven J Creely, Youssef-Elabd, E., Youssef-Elabd, Elham M., Harte, A., Abdalla, M., Creely, S., Ashour Esmat, da Silva, Nancy F., McTernan Philip G, Mohga S Abdalla, Day, C.P., Day, Christopher Paul, Billyard, T., Burt, Alastair D., Burt Alastair D, Philip G McTernan, Kumar, S., Elham M Youssef-Elabd, da Silva, N.F., Alison L Harte, Burt, A.D., Nancy F da Silva, Amin, Ashraf I., Tripathi, Gyanendra, Sharada, H., Burt, A., McTernan, P. G., Billyard, Thomas, da Silva, N., Harte, A.L., Day Christopher P, Youssef-Elabd Elham M, Tripathi Gyanendra, Alastair D Burt, Sharada, Hayat M., Hayat M Sharada, Kumar Sudhesh, Abdalla Mohga S, Sharada, H.M., Day, C., Abdalla, Mohga S., Sudhesh Kumar, Creely, S.J., McGee Kirsty C, Esmat Ashour, McTernan, P., Abdalla, M.S., Tripathi, G., McGee, K.C., Youssef-Elabd, E.M., Kirsty C McGee, Christopher P Day, Ashour, Esmat, McGee, K., Billyard Thomas, Gyanendra Tripathi, Thomas Billyard, Kumar, Sudhesh, Amin Ashraf I, Amin, A., da Silva Nancy F, Harte, A. L., Ashraf I Amin, McTernan, P.G., Creely, Steven J., McGee, K. C., Harte Alison L, Creely Steven J, Sharada Hayat M, Amin, A.I.   +70 more
core   +1 more source

Insulin sensitisers in the treatment of non-alcoholic fatty liver disease : a systematic review [PDF]

, 2011
Non-alcoholic fatty liver disease (NAFLD) is closely linked with obesity and the prevalence of NAFLD is about 17% to 33% in the Western world. There is a strong association of NAFLD with insulin resistance and, hence, insulin sensitisers have been tried.
C Clar, Henderson, R., Gurung, T., N Waugh, N Sattar, N Ghouri, Clar, C., Sattar, Naveed, Sattar, N., Fraser, A., T Gurung, Gurung, T. (Tara), D Shyangdan, A Fraser, Shyangdan, D., D Preiss, Waugh, Norman, Shyangdan, D. (Deepson), R Henderson, Ghouri, N., Preiss, D., Waugh, N.   +21 more
core   +1 more source

Management of non-alcoholic fatty liver disease incidentally detected during other medical assessments

, 2023
Elevated liver enzyme levels are a frequent incidental finding in primary care, and non-alcoholic fatty liver disease is the main cause of incidental elevation of liver enzymes worldwide.
Yeong Yeh Lee, Vincent Tee
core   +1 more source

Rodent models of fatty liver diseases

Liver Research, 2018
Fatty liver diseases including alcoholic liver disease (ALD) and non-alcoholic fatty liver disease (NAFLD) are leading causes of chronic liver diseases worldwide.
Adeline Bertola
doaj   +1 more source

Implications of Mitochondrial Unfolded Protein Response and Mitokines: A Perspective on Fatty Liver Diseases [PDF]

Endocrinology and Metabolism, 2019
The signaling network of the mitochondrial unfolded protein response (UPRmt) and mitohormesis is a retrograde signaling pathway through which mitochondria-to-nucleus communication occurs in organisms. Recently, it has been shown that the UPRmt is closely
Hyon-Seung Yi
doaj   +1 more source

Performance of Biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in Patients with Severe Obesity: Meta Analysis of Individual Patient Data [PDF]

, 2012
Background Liver biopsy is considered as the gold standard for assessing non-alcoholic fatty liver disease (NAFLD) histologic lesions in patients with severe obesity.
Mathurin, Philippe, Karine Clement (2245), Poynard, Thierry, Charlotte, Frederic, Guillaume Lassailly, Emmanuel Diaz, Philippe Mathurin (177542), Caıazzo, Robert, Demol, Bernard, Tordjman, Joan, Guillaume Lassailly (177527), François Pattou, Pierre Bedossa, Perazzo Hugo, Vlad Ratziu (38088), Robert Callafe (177536), Bedossa, Pierre, Ratziu, Vlad, Clement Karine, Charlotte Frederic, Munteanu Mona, Bernard Demol (177533), Pattou, François, FLIP consortium, Frederic Charlotte (43075), Pierre Bedossa (48266), Emmanuel Diaz (177528), Thierry Poynard (38084), Lassailly, Guillaume, Joan Tordjman (48258), Lassailly Guillaume, Bernard Demol, Mathurin Philippe, Tordjman Joan, Frederic Charlotte, Clement, Karine, Karine Clement, Joan Tordjman, Robert Caïazzo (177530), Perazzo, Hugo, Mona Munteanu (38097), Bedossa Pierre, Philippe Mathurin, Ratziu Vlad, Thierry Poynard, Mona Munteanu, Callafe Robert, Pattou François, Robert Caïazzo, Diaz Emmanuel, Hugo Perazzo (143739), Demol Bernard, Caïazzo Robert, Callafe, Robert, Munteanu, Mona, Diaz, Emmanuel, Hugo Perazzo, Robert Callafe, Vlad Ratziu, François Pattou (145757), Poynard Thierry   +60 more
core   +2 more sources

Specificities of lipotoxicity of free fatty acids and cytokine profile in patients with chronic diffuse liver diseases

Regulatory Mechanisms in Biosystems, 2021
Non-alcoholic fatty liver disease is an important cause of global liver disease characterized by diffuse hepatocytes with hepatocellular ballooning, intrahepatic inflammation and progressive fibrosis.
V. I. Didenko, I. A. Klenina, О. M. Tatarchuk, O. I. Hrabovska, O. P. Petishko   +4 more
doaj   +1 more source

Risk of liver dysfunction and non-alcoholic fatty liver diseases in people with hidradenitis suppurativa: A systematic review and meta-analysis of real-world evidences

Frontiers in Immunology, 2022
BackgroundTo date, evidences with high evidence-level evaluating the association between liver diseases and hidradenitis suppurativa was lacking. Given that inconsistency exists in some of the previous observational studies, evaluating the prevalence of ...
Shuo-Yan Gau, Shuo-Yan Gau, Yu-Ping Hsiao, Yu-Ping Hsiao, Wen-Chieh Liao, Kevin Sheng-Kai Ma, Kevin Sheng-Kai Ma, Kevin Sheng-Kai Ma, Meng-Che Wu, Meng-Che Wu, Meng-Che Wu   +10 more
doaj   +1 more source